NCT06740240View on ClinicalTrials.gov

68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

December 31, 2026

Conditions
Tumor
Interventions
DRUG

68Ga-FAPI-Biotin

Intravenous injection of one dosage of 111-148 MBq (3-4 mCi) 68Ga-FAPI-Biotin. Tracer doses of 68Ga-FAPI-Biotin will be used to detect tumors by PET/CT

DRUG

68Ga-FAPI/18F-FDG

Intravenous injection of one dosage of 111-148 MBq (3-4 mCi) 68Ga-FAPI or 3.7 MBq (0.1 mCi)/Kg 18F-FDG. Tracer doses of 68Ga-FAPI/18F-FDG will be used to detect tumors by PET/CT.

Trial Locations (1)

Unknown

RECRUITING

First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

First Affiliated Hospital of Fujian Medical University

OTHER